FindTrial
Sign In

Use of molecules to increase sperm motility

Exploring the sperm motility enhancement properties of pharmacologically active novel heterocycles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054719
Enrollment
65
Registered
2023-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N46- Male infertility

Interventions

Intervention1: Nil: Nil Intervention2: Chemically synthesized heterocyclic compounds: We are not using this compounds directly on patients. We will screen these compounds under invitro condition. Cont

Sponsors

Partial support (SERB grant)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults male between 18 to 50 years of age

Exclusion criteria

Exclusion criteria: Adults male above 50 years of age

Design outcomes

Primary

MeasureTime frame
Primary screening will help to identify specific concentration of molecules which helps to improve sperm motility enhancement propertyTimepoint: 1.5 years ( 72 weeks)—

Secondary

MeasureTime frame
This study will help to identify lead molecules to improve sperm motilityTimepoint: 1 year (48 weeks)—

Countries

India

Contacts

Public ContactGuruprasad Kalthur

Kasturba Medical College, Manipal

guru.kalthur@manipal.edu9886300179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026